Geron | Kostnadene For Salg



Cost Of Sales Endring Dato
Amgen USD 3.11B 198M 2024-12
Bio Techne USD 100.45M 1.09M 2024-12
Cassava Sciences 97.2K 16.13M 2024-06
Cytokinetics 463K 79.14M 2024-09
Exelixis USD 19.96M 2.64M 2025-01
Genmab DKK 337M 64M 2024-12
Geron 783K 327K 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
Incyte USD 82.38M 2.49M 2024-12
MacroGenics USD 5.49M 3.62M 2024-12
Novartis USD 3.32B 90M 2024-12



Geron Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.